{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:51:16Z","timestamp":1789995076549,"version":"4.0.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0057581","type":"journal-article","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T03:14:38Z","timestamp":1362194078000},"page":"e57581","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["Comprehensive Analysis of BRCA1, BRCA2 and TP53 Germline Mutation and Tumor Characterization: A Portrait of Early-Onset Breast Cancer in Brazil"],"prefix":"10.1371","volume":"8","author":[{"given":"Dirce Maria","family":"Carraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida Azevedo","family":"Koike Folgueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Cristina","family":"Garcia Lisboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa Helena","family":"Ribeiro Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Vitorino Krepischi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Fiorini","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Danielle","family":"de Carvalho Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato David","family":"Puga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"do Socorro Maciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Augusto Depieri","family":"Michelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Carneiro","family":"de Lyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stana Helena Giorgi","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Augusto","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel Alves","family":"de Souza Waddington Achatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Brentani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto","family":"Moreira-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Mitzi","family":"Brentani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/cncr.21070","article-title":"Women age<or = 35 years with primary breast carcinoma: disease features at presentation","volume":"103","author":"AM Gonzalez-Angulo","year":"2005","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7150\/ijms.5.197","article-title":"BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases","volume":"5","author":"N Uhrhammer","year":"2008","journal-title":"Int J Med Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.breast.2009.11.001","article-title":"Breast-conserving surgery in 201 very young patients (<35 years)","volume":"19","author":"O Gentilini","year":"2010","journal-title":"Breast"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/annonc\/mdq072","article-title":"Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer","volume":"21","author":"G Cancello","year":"2010","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.breast.2011.07.012","article-title":"Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: a retrospective matched case-control study","volume":"20","author":"R Peng","year":"2011","journal-title":"Breast"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/15287391003744773","article-title":"Environmental exposure and breast cancer among young women in Rio de Janeiro, Brazil","volume":"73","author":"GP Ortega Jacome","year":"2010","journal-title":"J Toxicol Environ Health A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1471-2407-6-194","article-title":"Effects of young age at presentation on survival in breast cancer","volume":"6","author":"NS El Saghir","year":"2006","journal-title":"BMC Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","article-title":"Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression","volume":"26","author":"CK Anders","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-009-0388-z","article-title":"Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer","volume":"119","author":"W Han","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0960-9776(03)00095-X","article-title":"Breast cancer in young women: clinicopathological features and biological specificity","volume":"12","author":"A Sidoni","year":"2003","journal-title":"Breast"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/00313020600699268","article-title":"Breast carcinoma in women 35 years and younger: a pathological study","volume":"38","author":"SM Fernandopulle","year":"2006","journal-title":"Pathology"},{"key":"ref12","first-page":"1341","article-title":"Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res","volume":"18(5)","author":"HA Azim Jr","year":"2012","journal-title":"1"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/annonc\/mdf039","article-title":"Very young women (<35 years) with operable breast cancer: features of disease at presentation","volume":"13","author":"M Colleoni","year":"2002","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"CM Perou","year":"2000","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/cncr.25746","article-title":"The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases","volume":"117","author":"CK Anders","year":"2011","journal-title":"Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ejca.2005.11.032","article-title":"BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives","volume":"42","author":"F Lalloo","year":"2006","journal-title":"Eur J Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc2054","article-title":"Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations","volume":"7","author":"JD Fackenthal","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/annonc\/mdp051","article-title":"Breast cancer in young women (YBC): prevalence of BRCA1\/2 mutations and risk of secondary malignancies across diverse racial groups","volume":"20","author":"BG Haffty","year":"2009","journal-title":"Ann Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2007.01.010","article-title":"Ten genes for inherited breast cancer","volume":"11","author":"T Walsh","year":"2007","journal-title":"Cancer Cell"},{"key":"ref20","first-page":"782","article-title":"The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2","volume":"6","author":"SR Lakhani","year":"2000","journal-title":"Clin Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10549-004-1536-0","article-title":"Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers","volume":"90","author":"J Palacios","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ejca.2006.12.009","article-title":"Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1\/2 families as compared to sporadic breast cancer cases","volume":"43","author":"CT Brekelmans","year":"2007","journal-title":"Eur J Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1073\/pnas.0533805100","article-title":"Molecular classification of familial non-BRCA1\/BRCA2 breast cancer","volume":"100","author":"I Hedenfalk","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1158\/0008-5472.CAN-05-0570","article-title":"Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization","volume":"65","author":"G J\u00f6nsson","year":"2005","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1186\/bcr3109","article-title":"Germline DNA copy number variation in familial and early-onset breast cancer","volume":"14","author":"AC Krepischi","year":"2012","journal-title":"Breast Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"LA Carey","year":"2006","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1158\/1078-0432.CCR-05-2230","article-title":"Characterization of familial non-BRCA1\/2 breast tumors by loss of heterozygosity and immunophenotyping","volume":"12","author":"RA Oldenburg","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref28","first-page":"54","article-title":"[Immunophenotype and evolution of breast carcinomas: a comparison between very young and postmenopausal women]","volume":"31","author":"MC Dutra","year":"2009","journal-title":"Rev Bras Ginecol Obstet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.breast.2010.01.002","article-title":"Estrogen receptor-positive breast carcinomas in younger women are different from those of older women: a pathological and immunohistochemical study","volume":"19","author":"LM Bacchi","year":"2010","journal-title":"Breast"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1590\/S0104-42302010000300010","article-title":"Molecular characterization of breast cancer in young Brazilian women","volume":"56","author":"LV Carvalho","year":"2010","journal-title":"Rev Assoc Med Bras"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1590\/S1415-47572004000400006","article-title":"BRCA1 mutations in Brazilian patients","volume":"27","author":"VF Louren\u00e7o JJ","year":"2004","journal-title":"Genetics and Molecular Biology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10549-006-9433-3","article-title":"Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study","volume":"105","author":"JC Figueiredo","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1399-0004.2007.00747.x","article-title":"Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus","volume":"71","author":"M Loizidou","year":"2007","journal-title":"Clin Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/gcc.20199","article-title":"Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France","volume":"43","author":"V Bonadona","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-9-86","article-title":"The prevalence of BRCA1 mutations among young women with triple-negative breast cancer","volume":"9","author":"SR Young","year":"2009","journal-title":"BMC Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-011-1711-z","article-title":"Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations","volume":"130","author":"S Bayraktar","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/bjc.2012.31","article-title":"BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years","volume":"106","author":"L Robertson","year":"2012","journal-title":"Br J Cancer"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10689-009-9287-z","article-title":"The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30","volume":"8","author":"OM Ginsburg","year":"2009","journal-title":"Fam Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/humu.21151","article-title":"Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect","volume":"31","author":"S Garritano","year":"2010","journal-title":"Hum Mutat"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2005.12.039","article-title":"The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families","volume":"245","author":"MI Achatz","year":"2007","journal-title":"Cancer Lett"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nature08021","article-title":"Genes that mediate breast cancer metastasis to the brain","volume":"459","author":"PD Bos","year":"2009","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"7434","DOI":"10.1158\/1078-0432.CCR-04-0548","article-title":"Gene expression profile associated with response to doxorubicin-based therapy in breast cancer","volume":"11","author":"MA Folgueira","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/bcr2157","article-title":"Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma","volume":"10","author":"NP Castro","year":"2008","journal-title":"Breast Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"T S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"JS Parker","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nrc2967","article-title":"Integrin signalling adaptors: not only figurants in the cancer story","volume":"10","author":"S Cabodi","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1038\/onc.2010.128","article-title":"p140Cap dual regulation of E-cadherin\/EGFR cross-talk and Ras signaling in tumour cell scatter and proliferation","volume":"29(25)","author":"L Damiano","year":"2010","journal-title":"Oncogene"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.jacc.2004.08.058","article-title":"Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy","volume":"44(11)","author":"T Hayashi","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-006-9378-6","article-title":"Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil","volume":"103","author":"MC Gomes","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cancergencyto.2008.03.011","article-title":"Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome","volume":"184","author":"EC da Costa","year":"2008","journal-title":"Cancer Genet Cytogenet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0057581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T06:44:29Z","timestamp":1562741069000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0057581"}},"subtitle":[],"editor":[{"given":"Paolo","family":"Peterlongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0057581","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,1]]}}}